CORAL WAY PHARMA
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99104421
- Mark type
- Stylized text
- Filed
- 26 Mar 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- David Greer Henry
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals; Antibacterial pharmaceuticals; Ocular pharmaceuticals; Anti-diabetic pharmaceuticals; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Therapeutic pharmaceutical for the treatment of inflammation.
Owner
- Coral Way Pharma, LLC, Laredo, TX, US
- Coral Way Pharma, LLC, Laredo, TX, US
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 26 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 26 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 25 Aug 2025 — ASSIGNED TO EXAMINER
- 26 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Mar 2025 — NEW APPLICATION ENTERED